Macular Degeneration Intravitreal Triamcinolone Acetonide Injection

Written by on April 21, 2011 in Treatments - No comments
Macular Degeneration Injection

Wet or exudative AMD has proven to be an increasingly common condition among the elderly and many are looking at studies involving exudative age related macular degeneration treated by an intravitreal triamcinolone acetonide injection with hopes of finding a cure. Although there is still no known cure for wet or exudative AMD, these studies do show some hope of short term benefits. Here we will look at what has been shown with the studies of exudative age related macular degeneration treated by intravitreal triamcinolone acetonide in a way that is understandable, even if you are not a scientist!

Indiana University’s Study

At the Indiana University School of Medicine in Indianapolis, there was a study published in the year 2000 to study exudative age related macular degeneration treated by intravitreal triamcinolone acetonide.

They used 27 patients and tested them at 3 and 6 months after injections of 4 mg to see what the effects were of exudative age related macular degeneration treated by intravitreal triamcinolone acetonide. They found that the people who had received the treatment did experience short term improvements in their ability to see. They also point out that they cannot actually prove that there is success for exudative age related macular degeneration treated by intravitreal triamcinolone acetonide until there are more studies done with more places, people, placebos and long term follow-ups.

Manheim of the University, Heidelberg, Germany

In this experiment which was also published in the year 2000, there were 187 people studied; 115 of them receiving treatment and the rest receiving nothing. The purpose was to study the effects of exudative age related macular degeneration treated by intravitreal triamcinolone acetonide. They used 25 mg, which is more than the previous experiment.

They tested the groups at one month and three months after the treatment or lack thereof, and found that the group receiving treatment had a significantly increased level of visual acuity.

Retina Vitreous Center, New Brunswick, New Jersey

In an experiment published in 2009, the effects of exudative age related macular degeneration treated by intravitreal triamcinolone acetonide were studied to see if it might be effective as a treatment before getting photodynamic therapy.

In this experiment, they studied 70 eyes of 66 patients who all received the intravitreal triamcinolone acetonide one week before getting PDT. There were some patients who had previously responded poorly to PDT and another group that had never received PDT in the past.

What they found was that exudative age related macular degeneration treated by intravitreal triamcinolone acetonide injection can help people require less PDT treatments in the future. It is their belief that combining the two treatments is better than using PDT alone.

Intravitreal Triamcinolone Acetonide injection work for some

These three experiments are all slightly different but were all attempting to measure aspects of age related macular degeneration treated by intravitreal triamcinolone acetonide. The results seem to show that this treatment may be effective for some people, especially if they want to get PDT in the future. Because of the sometimes devastating nature of AMD, it is wonderful that people are continuing to work towards finding a cure by researching effects of exudative age related macular degeneration treated by intravitreal triamcinolone acetonide.

Leave a Comment